Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Market Cap	6.45B -6.0%
Revenue (ttm)	1.51B -6.1%
Net Income	397.22M -20.6%
EPS	0.47 -20.6%
Shares Out	837.10M
PE Ratio	16.25
Forward PE	14.55
Dividend	0.37 (4.80%)
Ex-Dividend Date	Jun 12, 2026

Volume	1,745,000
Average Volume	1,146,951
Open	7.78
Previous Close	7.78
Day's Range	7.68 - 7.78
52-Week Range	7.66 - 9.72
Beta	0.36
RSI	22.88
Earnings Date	Mar 20, 2026

About HKG:3613

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. It operates through three segments: Hong Kong, Mainland China, and Overseas. The company offers Chinese medical consultation and treatment services. It also operates retail outlets in Hong Kong and in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand name. Be...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1669
• Employees: 789
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3613

Financial Performance

In 2025, HKG:3613's revenue was 1.51 billion, a decrease of -6.10% compared to the previous year's 1.61 billion. Earnings were 397.22 million, a decrease of -20.60%.